mitoxantrone has been researched along with Adenocarcinoma Of Kidney in 4 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izumi, K | 1 |
| Kanno, H | 1 |
| Umemoto, S | 1 |
| Hasumi, H | 1 |
| Osada, Y | 1 |
| Otai, J | 1 |
| Mikata, K | 1 |
| Tsuchiya, F | 1 |
| Nagashima, Y | 1 |
| van Oosterom, AT | 1 |
| Fosså, SD | 1 |
| Pizzocaro, G | 1 |
| Bergerat, JP | 1 |
| Bono, AV | 1 |
| De Pauw, M | 1 |
| Sylvester, R | 1 |
| Oliver, RT | 1 |
| Miller, RM | 1 |
| Mehta, A | 1 |
| Barnett, MJ | 1 |
| Gams, RA | 1 |
| Nelson, O | 1 |
| Birch, R | 1 |
1 trial available for mitoxantrone and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Phase II evaluation of mitoxantrone in advanced renal cell carcinoma: a Southeastern Cancer Study Group Trial.
Topics: Adult; Anthraquinones; Antineoplastic Agents; Carcinoma, Renal Cell; Clinical Trials as Topic; Drug | 1986 |
3 other studies available for mitoxantrone and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
[A case of recurrent renal cell carcinoma which recurred after fourth surgical resection and survived for about 2 years by medroxyporgesterone acetate administration].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Ce | 2007 |
Mitoxantrone in advanced renal cancer: a phase II study in previously untreated patients from the EORTC Genito-Urinary Tract Cancer Cooperative Group.
Topics: Adult; Aged; Anthraquinones; Antineoplastic Agents; Carcinoma, Renal Cell; Drug Evaluation; Female; | 1984 |
A phase 2 study of surveillance in patients with metastatic renal cell carcinoma and assessment of response of such patients to therapy on progression.
Topics: BCG Vaccine; Carcinoma, Renal Cell; Drug Evaluation; Follow-Up Studies; Humans; Interferon Type I; K | 1988 |